COMBINATION THERAPY COMPRISING SGLT INHIBITORS AND DPP4 INHIBITORS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20140371162A1
SERIAL NO

14472037

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to combination therapy comprising a DPP4 inhibitor and an SGLT inhibitor. The combination of the present invention leads to increase plasma GLP-1 level and the combination is useful for prevention or treatment of conditions such as diabetes and diseases related to diabetes.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MITSUBISHI TANABE PHARMA CORPORATIONOSAKA-SHI OSAKA 541-8505

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Arakawa, Kenji Osaka-shi, JP 34 308
Matsushita, Yasuaki Osaka-shi, JP 31 112
Ueta, Kiichiro Osaka-shi, JP 10 126

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation